Free Account Opening + AMC Free Demat
Loading...

Alkem Laboratories IPO vs TeamLease Services IPO

Comparision between Alkem Laboratories IPO and TeamLease Services IPO.

IPO Details

Alkem Laboratories IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while TeamLease Services IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Alkem Laboratories IPO is up to ₹1,349.61 Cr whereas the issue size of the TeamLease Services IPO is up to ₹423.68 Cr. The final issue price of Alkem Laboratories IPO is ₹1,050.00 per share and of TeamLease Services IPO is ₹850.00 per share.

  Alkem Laboratories IPO TeamLease Services IPO
Face Value ₹2 per share ₹10 per share
Issue Price (Lower) ₹1,020.00 per share ₹785.00 per share
Issue Price (Upper) ₹1,050.00 per share ₹850.00 per share
Issue Price (Final) ₹1,050.00 per share ₹850.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 14 shares 15 shares
Fresh Issue Size 17,64,705 shares
Fresh Issue Size (Amount) up to ₹150.00 Cr
OFS Issue Size 32,09,733 shares
OFS Issue Size (Amount) up to ₹272.83 Cr
Issue Size Total 1,28,53,442 shares 49,74,438 shares
Issue Size Total (Amount) up to ₹1,349.61 Cr up to ₹423.68 Cr

IPO Timetable

Alkem Laboratories IPO opens on Dec 08, 2015, while TeamLease Services IPO opens on Feb 02, 2016. The closing date of Alkem Laboratories IPO and TeamLease Services IPO is Dec 10, 2015, and Feb 04, 2016, respectively.

  Alkem Laboratories IPO TeamLease Services IPO
Anchor Bid Date
Issue Open Dec 08, 2015 Feb 02, 2016
Issue Close Dec 10, 2015 Feb 04, 2016
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkem Laboratories IPO P/E ratio is , as compared to TeamLease Services IPO P/E ratio of .

  Alkem Laboratories IPO TeamLease Services IPO
Financial
ParticularsFor the year/period ended (in Rs. Million)
31 Mar 1531 Mar 1431 Mar 1331 Mar 12
Total Income33,595.2028,395.8024,690.1020,640.10
Profit After Tax (PAT)4,370.904,402.004,667.804,318.10

Particulars

For the year/period ended (in Rs. Million)
31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12 31-Mar-11
Total Liabilities 3,505.18 2,432.83 2,242.29 1,968.99 965.45
Total Assets 3,505.18 2,432.83 2,242.29 1,968.99 965.45
Total Income 20,184.60 15,375.25 12,616.91 9,340.89 6,983.24
Profit After Tax (PAT) 296.90 178.57 (37.00) (164.97) (394.87)
Promoter Shareholding (Pre-Issue) 70.87% 51.86%
Promoter Shareholding (Post-Issue) 66.23% 19.99%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 15.4%%

Shares Offered

In the Alkem Laboratories IPO retail investors (RII) are offered 43,94,086 shares while in TeamLease Services IPO retail investors are offered 43,94,086 shares. Qualified institutional buyers (QIB) are offered 25,10,906 shares in Alkem Laboratories IPO and 16,01,923 shares in TeamLease Services IPO.

  Alkem Laboratories IPO TeamLease Services IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 25,10,906 shares 16,01,923 shares
NII 18,83,179 shares 7,68,084 shares
RII 43,94,086 shares 5,12,056 shares
Employee 2,98,913 shares 10,000 shares
Others
Total 90,87,084 shares 28,92,063 shares

Bids Received (Subscription)

Alkem Laboratories IPO subscribed 44.29x in total, whereas TeamLease Services IPO subscribed 66.02x.

  Alkem Laboratories IPO TeamLease Services IPO
QIB (times) 57.19x 26.97x
NII (times) 129.96x 185.24x
Big NII (times)
Small NII (times)
RII (times) 3.17x 10.61x
Employee (times) 0.67x 1.39x
Other (times)
Total (times) 44.29x 66.02x

Comments

Add a public comment...